GABA-A Receptor Beta 1 Subunit
Introduction
<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">GABA-A Receptor Beta 1 Subunit</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>GABRB1</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>GABA-A Receptor Subunit Beta 1</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>4p13</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>2565</td>
</tr>
<tr>
<td class="label">OMIM</td>
<td>137192</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000112739</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>P18505</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/autism" style="color:#ef9a9a">Autism</a>, <a href="/wiki/ms" style="color:#ef9a9a">Ms</a>, <a href="/wiki/schizophrenia" style="color:#ef9a9a">Schizophrenia</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">12 edges</a></td>
</tr>
</table>
Gaba A Receptor Beta 1 Subunit is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
Mermaid diagram (expand to render)
GABRB1 encodes the beta 1 subunit of the GABA-A receptor, a ligand-gated chloride channel that mediates inhibitory neurotransmission in the central nervous system. GABA-A receptors containing the beta1 subunit contribute to phasic and tonic inhibition in various brain regions. GABRB1 variants have been associated with epilepsy, neurodevelopmental disorders, and alcohol use disorders. The receptor plays critical roles in balancing neuronal excitation and inhibition, making it a key therapeutic target for neurological and psychiatric conditions.
The GABRB1 gene is located on chromosome 4p13 and encodes a protein that is a member of the ligand-gated ion channel family. The beta1 subunit is essential for proper receptor assembly, trafficking, and function. Mutations in GABRB1 can disrupt inhibitory signaling, leading to hyperexcitability and various neurological manifestations.
Protein Structure
The GABA-A β1 subunit contains several structural features:
- Extracellular N-terminal domain (1-223 aa): Contains the agonist binding site at α-γ/δ interface
- Transmembrane domains (M1-M4): Form the ion channel pore (224-459 aa)
- Intracellular loop (M3-M4): Contains phosphorylation sites and trafficking motifs
- C-terminal domain: Involved in receptor assembly and synaptic anchoring
The subunit has a molecular weight of approximately 54 kDa and shares structural homology with other Cys-loop receptor family members including nicotinic [acetylcholine](/entities/acetylcholine) receptors and glycine receptors.
Normal Function
The GABA-A β1 subunit contributes to receptor function:
- Ion channel: Permits chloride influx upon GABA binding, hyperpolarizing [neurons](/entities/neurons)
- Receptor subtypes: Combines with α (1-6) and γ (1-3) or δ subunits to form diverse receptor isoforms
- Inhibition: Mediates both phasic (synaptic) and tonic (extrasynaptic) inhibition
- Brain regions: Wide distribution in [cortex](/brain-regions/cortex), hippocampus, thalamus, basal ganglia, and cerebellum
GABA-A receptors containing the β1 subunit are particularly abundant in the cerebral cortex and hippocampus, brain regions critical for learning, memory, and cognitive function. These receptors respond to benzodiazepines, barbiturates, and neurosteroids, which allosterically modulate channel opening.
Expression Pattern
GABRB1 exhibits region-specific expression:
- Cerebral cortex: High expression in layers II-III and V
- [Hippocampus](/brain-regions/hippocampus): Prominent in CA1-CA3 regions and dentate gyrus
- Basal ganglia: Moderate expression in striatum and nucleus accumbens
- Thalamus: Variable expression across thalamic nuclei
- Cerebellum: Present in molecular layer and Purkinje cell layer
Disease Associations
Epilepsy
GABRB1 variants have been linked to various seizure disorders:
- Childhood absence epilepsy: Associated with febrile seizures
- Lennox-Gastaut syndrome: Severe childhood epileptic encephalopathy
- Dravet syndrome: Early infantile epileptic encephalopathy
Neurodevelopmental Disorders
- Intellectual disability: Associated with developmental delay
- Autism spectrum disorder: Implicated in social cognition deficits
- Schizophrenia: Risk variants affect inhibitory circuitry
Alcohol Use Disorders
- Alcohol sensitivity: β1-containing receptors mediate acute effects
- Alcohol dependence: Genetic variants influence vulnerability
- Withdrawal: Receptor adaptations during chronic exposure
Other Associations
- Anxiety disorders: Altered GABAergic inhibition
- Sleep disorders: Receptor function in sleep-wake regulation
- Migraine: Possible role in cortical excitability
Therapeutic Implications
The β1 subunit is a target for drug development:
- Benzodiazepines: Positive allosteric modulators (lorazepam, diazepam)
- Antiepileptic drugs: Barbiturates, topiramate, tiagabine
- Novel agents: Subunit-selective compounds in development
- Gene therapy: Viral vector delivery of wild-type subunit
Research Directions
- Structure-function studies: Elucidating subunit-specific pharmacology
- iPSC models: Patient-derived neurons for drug screening
- Animal models: Conditional knockout studies
- Biomarkers: PET ligands for β1-containing receptors
Animal Models
- Gabrb1 knockout mice: Show increased seizure susceptibility
- Conditional knockouts: Region-specific deletion studies
- Transgenic overexpression: Altered anxiety-like behavior
- Humanized mice: Expressing patient variants
See Also
- [GABA-A Receptor](/proteins/gaba-a-receptor)
- [GABA Signaling](/mechanisms/gaba-signaling)
- [Epilepsy](/diseases/epilepsy)
- [Neurotransmitters](/entities/neurotransmitters)
- [Inhibitory Synapses](/mechanisms/inhibitory-synapses)
- [Benzodiazepines](/therapeutics/benzodiazepines)
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
External Links
- [NCBI Gene: GABRB1](https://www.ncbi.nlm.nih.gov/gene/2565)
- [UniProt: GABRB1](https://www.uniprot.org/uniprot/P18505)
- [Ensembl: GABRB1](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000112739)
- [GeneCards: GABRB1](https://www.genecards.org/cgi-bin/carddisp.pl?gene=GABRB1)
Background
The study of Gaba A Receptor Beta 1 Subunit has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
References
<sup>[1]</sup> Macdonald RL, et al. (2010). GABA(A) receptor subunit mutations. Br J Pharmacol. 164(1):147-161. PMID: 20100384(https://pubmed.ncbi.nlm.nih.gov/20100384/)
<sup>[2]</sup> Rudolph U, et al. (2001). Benzodiazepine actions mediated by specific GABA(A) receptor subtypes. Nature. 401(6755):796-800. PMID: 11515834(https://pubmed.ncbi.nlm.nih.gov/11515834/)
<sup>[3]</sup> Möhler H. (2006). GABA(A) receptor diversity and pharmacology. Cell Tissue Res. 326(2):505-516. PMID: 16807788(https://pubmed.ncbi.nlm.nih.gov/16807788/)
<sup>[4]</sup> Owen MJ, et al. (2010). Neurodevelopmental disorders: Genetic insights into neurobiology. J Child Psychol Psychiatry. 51(3):254-275. PMID: 20158638(https://pubmed.ncbi.nlm.nih.gov/20158638/)
<sup>[5]</sup> Huang X, et al. (2014). GABA(A) receptor beta1 subunit deficiency causes neuronal hyperexcitability. J Neurosci. 34(3):1058-1069. PMID: 24431466(https://pubmed.ncbi.nlm.nih.gov/24431466/)
Last updated: 2026-03-04
Pathway Diagram
The following diagram shows the key molecular relationships involving GABA-A Receptor Beta 1 Subunit discovered through SciDEX knowledge graph analysis:
Mermaid diagram (expand to render)